Joseph Pike

Joseph Pike is a seasoned executive with extensive experience in the biotechnology and technology sectors. Currently serving as Chairman and Managing Member of Galleon Bio LLC since January 2016, Joseph is instrumental in developing clinical trials for innovative strontium platform molecules. In addition, Joseph has been the President and CEO of Evofem, Inc. since 2000, and previously held the CEO position at Instead, Inc. from 2000 to 2008, as well as at Beltronics LTD from 1997 to 1999. Joseph holds both a Bachelor's degree and a Juris Doctorate from the University of North Carolina at Chapel Hill, reflecting a strong academic background in law and business.